Supplier Part: RETEVAL-001
Buy In Item
RETeval-DR Electroretinograph is designed for healthcare providers who want to improve management of their patients with diabetes.
The RETeval-DR objectively screens for vision-threatening diabetic retinopathy with a 99.2% negative predictive value in just 3 minutes.
- Non-mydriatic for patient comfort
- Quickly screen for vision-threatening diabetic retinopathy wherever patients with diabetes receive their care
- Time savings for the clinician and patient
- No advanced clinical training is required to perform the test or read the results. ReTeval-DR provides immediate test results and report
- High accuracy and low technical failure rate
- A lower cost option compared to dilated eye exams and teleretinal imaging services
- Handheld and battery powered
Medicare Bene? ts Schedule Item Number 11204
Please enter your email address to subscribe to our newsletters.